  | GASPARD, U., Taziaux, M., Mawet, M., Jost, M., Gordenne, V., Coelingh Bennink, H. J. T., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (August 2020). A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause (New York, N.Y.), 27 (8), 848-857. doi:10.1097/GME.0000000000001561  Peer reviewed |
 | Grobet, M., CAPELLE, X., Willems, T., Triffaux, J.-M., GASPARD, U., & Kridelka, F. (2020). "Je ne suis pas enceinte !" A propos du déni de grossesse. Revue Médicale de Liège, 75. Peer reviewed |
Foidart, J.-M., GASPARD, U., Pequeux, C., Jost, M., Gordenne, V., Tskitishvili, E., Gallez, A., Valera, M.-C., Gourdy, P., Fontaine, C., Henrion, D., Genazzani, A. R., Lenfant, F., & Arnal, J.-F. (2019). Unique Vascular Benefits of Estetrol, a Native Fetal Estrogen with Specific Actions in Tissues (NEST). In R. Diaz Brinton, A. Genazzani, T. Simoncini, ... J. Stevenson, Sex Steroids' Effects on Brain, Heart and Vessels: Volume 6: Frontiers in Gynecological Endocrinology. Cham, Switzerland: Springer Nature. doi:10.1007/978-3-030-11355-1 Peer reviewed |
  | Slomian, J., Reginster, J.-Y., Gaspard, U., Streel, S., Beaudart, C., Appelboom, G., Buckinx, F., & Bruyère, O. (2015). Exploring the Interest in and the Usage of the Internet Among Patients Eligible for Osteoporosis Screening. Calcified Tissue International, 96, 518-526. doi:10.1007/s00223-015-9987-3 Peer Reviewed verified by ORBi |
 | Pierard, G., Hermanns-Lê, T., Gaspard, U., & Pierard-Franchimont, C. (2014). Asymmetric facial skin viscoelasticity during climacteric aging. Clinical, Cosmetic and Investigational Dermatology, 7, 111-8. doi:10.2147/CCID.S60313 Peer Reviewed verified by ORBi |
 | Slomian, J., GASPARD, U., Reginster, J.-Y., Streel, S., Beaudart, C., Appelboom, G., Buckinx, F., & Bruyère, O. (2014). Des interventions de prévention ou de promotion de la santé utilisant Internet pourraient-elles être prometteuses chez des femmes aux alentours de la ménopause ? Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 205. Peer Reviewed verified by ORBi |
 | PIERARD, G., Humbert, P., Berardesca, E., Gaspard, U., Hermanns-Lê, T., & Franchimont, C. (2013). Revisiting the cutaneous impact of oral hormone replacement therapy. BioMed Research International, 2013 (971760). doi:10.1155/2013/971760 Peer Reviewed verified by ORBi |
 | PINTIAUX, A., Gaspard, U., & Nisolle, M. (2012). Le médicament du mois. Zoely®, une association monophasique d’estradiol et d’acétate de nomégestrol. Revue Médicale de Liège, 67 (3), 152-6. Peer reviewed |
 | SCHEEN, A., & Gaspard, U. (2011). Le medicament du mois. Femoston Low (0,5 mg d'estradiol plus 2,5 mg de dydrogesterone) comme traitement hormonal de substitution a la menopause. Revue Médicale de Liège, 66 (4), 209-14. Peer reviewed |
 | DESREUX, J., Gaspard, U., BLERET, V., Van Cauwenberge, J.-R., THILLE, A., HERMAN, P., & LIFRANGE, E. (2011). Le cancer du sein en Belgique: pourquoi sommes-nous les premiers en Europe? Revue Médicale de Liège, 66 (5-6), 231-7. Peer reviewed |
 | Gaspard, U., & Kridelka, F. (2010). Le medicament du mois. Ulipristal acetate: une contraception d'urgence etendue a 5 jours par progesterone receptor modulator (Ellaone). Revue Médicale de Liège, 65 (12), 700-5. Peer reviewed |
 | Devogelaer, J. P., Reginster, J.-Y., Rompen, E., Boutsen, Y., Body, J. J., Bergmann, P., Rozenberg, S., GASPARD, U., & Reychler, H. (2010). L'ostéonécrose maxillaire associée aux traitements aux bisphosphonates dans le traitement de l'ostéoporose. Consensus interdisciplinaire. Louvain Medical, 129 (8), 305-309. Peer reviewed |
 | Gaspard, U., PINTIAUX, A., & Kridelka, F. (2010). Le médicament du mois. Nouvelle contraception orale combinée au valerate d'estradiol et au dienogest (Qlaira). Revue Médicale de Liège, 65 (12), 706-13. Peer reviewed |
 | Emonts, P., Seaksan, S., Seidel, L., Thoumsin, H., Gaspard, U., Albert, A., & Foidart, J.-M. (2008). Prediction of maternal predisposition to preeclampsia. Hypertension in Pregnancy, 27 (3), 237-45. doi:10.1080/10641950802000901 Peer Reviewed verified by ORBi |
 | DELCOMINETTE, S., & GASPARD, U. (2008). Dysfonction sexuelle féminine et androgénothérapie à la ménopause. Revue Médicale de Liège, 63, 23-30. Peer reviewed |
 | Pincemail, J., Vanbelle, S., Gaspard, U., Collette, G., Haleng, J., Cheramy-Bien, J. P., Charlier, C., Chapelle, J.-P., Giet, D., Albert, A., Limet, R., & Defraigne, J.-O. (August 2007). Effect of different contraceptive methods on the oxidative stress status in women aged 40-48 years from the ELAN study in the province of Liege, Belgium. Human Reproduction, 22 (8), 2335-2343. doi:10.1093/humrep/dem146 Peer Reviewed verified by ORBi |
 | Pierard, G., Pierard, C., Quatresooz, P., Kridelka, F., & Gaspard, U. (2007). Peut-on sortir de l'embrouillamini relatif aux contraceptifs oraux et aux cancers cutanés? Revue Médicale de Liège, 62 (5-6), 463-6. Peer reviewed |
 | HERMAN, P., Lifrange, E., Nisolle, M., Kridelka, F., Nervo, P., & Gaspard, U. (2007). Actualites therapeutiques en gynecologie: pathologies organiques. Revue Médicale de Liège, 62 (5-6, May-Jun), 414-22. Peer reviewed |
 | Thirion, L., Franchimont, C., Arrese Estrada, J., Quatresooz, P., Gaspard, U., & Pierard, G. (2006). La peau et le temps de la menopause. Revue Médicale de Liège, 61 (3), 159-62. Peer reviewed |
 | Quatresooz, P., Pierard, C., Gaspard, U., & Pierard, G. (2006). Skin climacteric aging and hormone replacement therapy. Journal of Cosmetic Dermatology, 5 (1), 3-8. doi:10.1111/j.1473-2165.2006.00215.x Peer Reviewed verified by ORBi |
 | RADERMECKER, M., Pierard, L., GASPARD, U., Baguet, E., & Limet, R. (March 2005). Le cas clinique du mois. Remplacement de l'aorte ascendante et conservation de la valve aortique: operation de David. Revue Médicale de Liège, 60 (3), 141-3. Peer reviewed |
 | Charlier, C., Foidart, J.-M., Pitance, F., Herman, P., Gaspard, U., Meurisse, M., & Plomteux, G. (2004). Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk? Clinical Chemistry and Laboratory Medicine, 42 (2), 222-227. doi:10.1515/CCLM.2004.040 Peer Reviewed verified by ORBi |
 | Pintiaux, A., Van den Brule, F., Foidart, J.-M., & Gaspard, U. (September 2003). Place du traitement substitutif de la menopause 1 an apres la publication des resultats de l'etude WHI (Women's Health Initiative). Revue Médicale de Liège, 58 (9), 572-5. Peer reviewed |
 | Charlier, C., Albert, A., Herman, P., Hamoir, E., Gaspard, U., Meurisse, M., & Plomteux, G. (May 2003). Breast cancer and serum organochlorine residues. Occupational and Environmental Medicine, 60 (5), 348-351. doi:10.1136/oem.60.5.348 Peer Reviewed verified by ORBi |
 | Lifrange, E., Bleret, V., Desreux, J., Dondelinger, R., Foidart, J.-M., Gaspard, U., Herman, P., Van Cauwenberge, J.-R., & Colin, C. (May 2003). Interet et limites du depistage de masse du cancer du sein par mammographie seule (mammotest). Revue Médicale de Liège, 58 (5), 331-7. Peer reviewed |
 | van den Brule, F., Lifrange, E., Pintiaux, A., Foidart, J.-M., & Gaspard, U. (April 2003). Hormonosubstitution postmenopausique et risque de cancer mammaire: une mise a jour. Revue Médicale de Liège, 58 (4), 254-60. Peer reviewed |
 | Gaspard, U., Scheen, A., Endrikat, J., Buicu, C., Lefebvre, P., Gerlinger, C., & Heithecker, R. (2003). A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism. Contraception, 67 (6), 423-9. doi:10.1016/S0010-7824(02)00537-1 Peer Reviewed verified by ORBi |
 | Gaspard, U., van den Brule, F., PINTIAUX, A., & Foidart, J.-M. (August 2002). L'etude clinique du mois. Balance benefice/risque du traitement oestroprogestatif postmenopausique en peril dans l'etude Women's Health Initiative: attitude pratique du clinicien. Revue Médicale de Liège, 57 (8), 556-62. Peer reviewed |
 | Ludicke, F., Gaspard, U., Demeyer, F., Scheen, A., & Lefebvre, P. (2002). Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception, 66 (6), 411-5. doi:10.1016/S0010-7824(02)00415-8 Peer Reviewed verified by ORBi |
 | Pierard, G., Pierard-Franchimont, C., Vanderplaetsen, S., Franchimont, N., GASPARD, U., & Malaise, M. (August 2001). Relationship between bone mass density and tensile strength of the skin in women. European Journal of Clinical Investigation, 31 (8), 731-735. doi:10.1046/j.1365-2362.2001.00841.x Peer Reviewed verified by ORBi |
 | Van den Brule, F., DESREUX, J., BELIARD, A., MASSON, V., Noël, A., Kebers, F., Thomas, J., GASPARD, U., & Foidart, J.-M. (2001). Influence du régime d’administration continu ou discontinu d’acétate de nomégestrol sur l’apoptose des cellules mammaires. Reproduction Humaine et Hormones, 15, 243-248. Peer reviewed |
LIFRANGE, E., BOURDOUX, B., DONDELINGER, R., Foidart, J.-M., FRIDMAN, V., GASPARD, U., HERMAN, P., DESREUX, J., Van Cauwenberge, J.-R., VENNEMAN, I., & COLIN, C. (2000). Prise en charge diagnostique et thérapeutique d'une opacité suspecte par la méthode ABBI. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 5, 14-15. Peer reviewed |
Legros, S., Foidart, J.-M., Gaspard, U., & Legros, J.-J. (April 1999). Le syndrome de tension prémenstruelle ou dysphorie prémenstruelle. Revue Médicale de Liège, 54 (4), 268-73. Peer reviewed |
Beckers, A., Parotte, M. C., Gaspard, U., & Khalife, A. (April 1999). Hyperandrogénie: sémiologie, exploration et traitement. Revue Médicale de Liège, 54 (4), 274-282. Peer reviewed |
LIFRANGE, E., BOURDOUX, B., DESREUX, J., DONDELINGER, R., Foidart, J.-M., FRIDMAN, V., GASPARD, U., HERMAN, P., Van Cauwenberge, J.-R., VENNEMAN, I., & COLIN, C. (1999). Prise en charge diagnostique d'un amas de calcifications atypiques par la méthode MIBB. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 4, 219-220. Peer reviewed |
LIFRANGE, E., DONDELINGER, R., Foidart, J.-M., GASPARD, U., HERMAN, P., LAMBOTTE, R., DESREUX, J., Van Cauwenberge, J.-R., & COLIN, C. (1999). Apport des techniques nouvelles d'imagerie médicale en gynécologie : sénologie interventionnelle, possibilités diagnostiques et thérapeutiques. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 4, 54. Peer reviewed |
Gaspard, U., Wery, O., Scheen, A., Jaminet, C., & Lefebvre, P. (1999). Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric: the Journal of the International Menopause Society, 2 (2), 93-100. doi:10.3109/13697139909025572 Peer Reviewed verified by ORBi |
Herman, P., Gaspard, U., & Foidart, J.-M. (December 1998). Hystéroscopie opératoire ou hystérectomie dans le traitement des lésions utérines bénignes. Que choisir en 1998? Revue Médicale de Liège, 53 (12), 756-61. Peer reviewed |
 | Stevenson, J., GASPARD, U., Avouac, B., Bricaire, C., Cardozo, L., Collins, P., Devogelaer, J., Dören, M., Gennari, C., Kaufman, J., Kuttenn, F., Ringe, J., Scarafiotti, C., Vanhaelst, L., Zichella, L., Ziegler, R., & Reginster, J.-Y. (1998). Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Climacteric: the Journal of the International Menopause Society, 1, 12-17. doi:10.3109/13697139809080676 Peer Reviewed verified by ORBi |
Biquet, G., BRICHANT, J.-F., DEWANDRE, P.-Y., De Sart, F., Dubois, M., Foidart, J.-M., Garnir, D., Gaspard, U., Gillot, M., Hardy, A.-F., Herman, P., Jacobs, J. L., Laloux, F., Lifrange, E., Retz, C., Rigo, J., Sérilas, M., Schaaps, J.-P., Theunissen, I., ... Van den Brule, F. (March 1997). Attitudes obstétricales: Consensus de Département ULg. Document des cours de troisième cycle, octobre 96. Revue Médicale de Liège, 52 (3), 142-8. Peer reviewed |
 | Capasso, P., Simons, C., Trotteur, G., DONDELINGER, R., Henroteaux, D., & Gaspard, U. (1997). Treatment of Symptomatic Pelvic Varices by Ovarian Vein Embolization. Cardiovascular and Interventional Radiology, 20 (2, Mar-Apr), 107-11. doi:10.1007/s002709900116 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Christiansen, C., Dequinze, B., Deroisy, R., Gaspard, U., Taquet, A. N., & Franchimont, P. (July 1993). Effect of Transdermal 17 Beta-Estradiol and Oral Conjugated Equine Estrogens on Biochemical Parameters of Bone Resorption in Natural Menopause. Calcified Tissue International, 53, 13-6. doi:10.1007/BF01352008 Peer Reviewed verified by ORBi |
Scheen, A., Jandrain, B., Humblet, D., Jaminet, C. B., Gaspard, U., & Lefebvre, P. (1993). Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism. Fertility and Sterility, 59 (4), 797-802. doi:10.1016/s0015-0282(16)55862-2 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Sarlet, N., Deroisy, R., Albert, A., Gaspard, U., & Franchimont, P. (November 1992). Minimal Levels of Serum Estradiol Prevent Postmenopausal Bone Loss. Calcified Tissue International, 51, 340-3. doi:10.1007/BF00316876 Peer Reviewed verified by ORBi |
Schoenen, J., Bottin, D., Sulon, J., GASPARD, U., & Lambotte, R. (May 1991). Exteroceptive Silent Period of Temporalis Muscle in Menstrual Headaches. Cephalalgia, 11 (2), 87-91. doi:10.1046/j.1468-2982.1991.1102087.x Peer Reviewed verified by ORBi |
RADERMECKER, M., Corhay, J.-L., Broux, R., Gustin, N., Noel, F., Borlee, G., BURY, T., Saint-Remy, P., Gaspard, U., & Limet, R. (1991). A propos de 2 cas de lymphangiomyomatose traités par agoniste de la LH-RH. Revue Médicale de Liège, 46 (5), 286-93. Peer reviewed |
David, J.-L., GASPARD, U., Gillain, D., Raskinet, R., & Lepot, M. R. (July 1990). Hemostasis Profile in Women Taking Low-Dose Oral Contraceptives. American Journal of Obstetrics and Gynecology, 163 (1, Pt 2), 420-3. doi:10.1016/0002-9378(90)90594-W Peer Reviewed verified by ORBi |
Jandrain, B., Humblet, D., Jaminet, C. B., Scheen, A., Gaspard, U., & Lefebvre, P. (1990). Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial. American Journal of Obstetrics and Gynecology, 163 (1 Pt 2), 378-81. doi:10.1016/0002-9378(90)90586-V Peer Reviewed verified by ORBi |
 | Sarlet, N., Reginster, J.-Y., GASPARD, U., DEROISY, R., Denis, D., Lecart, M., & Franchimont, P. (1989). Determination of minimal serum estradiol for prevention of postmenopausal bone loss. Calcified Tissue International, 44, 69. Peer Reviewed verified by ORBi |
 | Dokekias, A. E., Croisiaux, C., Andrien, F., Andre, C., Trotteur, G., Henrivaux, P., Gaspard, U., Rorive, G., & Fillet, G. (1989). Purpura thrombotique thrombocytopénique. Revue Médicale de Liège, 44, 601-609. Peer reviewed |
 | Reginster, J.-Y., Sarlet, N., DEROISY, R., Lecart, M., GASPARD, U., Albert, A., & Franchimont, P. (1989). Comparison of serum estrone levels, urinary calcium and urinary hydroxyproline in eugonadal and postmenopausal women with or without estrogen replacement therapy. Journal of Bone and Mineral Research, 4 (S1), 291. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Lecart, M., GASPARD, U., & Franchimont, P. (1988). Le point sur l'ostéoporose. Medical Trends, 7, 401-412. |
Graitson, M., Gaspard, U., Moonen, G., & Zicot, M. (01 December 1983). A problem checklist and the clinical resume. Revue Médicale de Liège, 38 (23), 897-905. Peer reviewed |
Foidart, J.-M., Yaar, M., Hall, R., GASPARD, U., & Katz, S. I. (1981). Immunopathological and clinical studies in herpes gestationis. British Journal of Obstetrics and Gynaecology, 88 (2), 153-9. doi:10.1111/j.1471-0528.1981.tb00961.x Peer Reviewed verified by ORBi |